基于德尔菲法的Fuchs内皮性角膜营养不良全球共识:内皮性角膜移植学习小组倡议
该改良德尔菲全球共识汇集37名国际FECD专家,经三轮问卷与线上会议形成91条陈述,其中90条达成共识(共识阈值70%同意)。共识明确FECD以中央或旁中央散在或融合的滴状疣定义为特征,可伴或不伴水肿;强调亚临床水肿先于临床可检测水肿;认为目前无有效药物治疗,有指征时Descemet膜内皮角膜移植术是首选手术。
要点
- FECD定义为中央或旁中央散在或融合的滴状疣,可伴或不伴水肿
- 慢性亚临床水肿状态先于临床可检测的水肿出现,后者可伴或不伴症状
- 目前无有效药物治疗FECD,有指征时Descemet膜内皮角膜移植术是首选手术
核心结论
- 该共识声明提供了当前获全球认可的FECD诊断与管理建议。
- 这些指南对通常首次诊断和评估FECD的普通眼科医生以及角膜专科医生都具有重要性和相关性,使其能对照专家建议衡量自身实践模式。
- 这有助于改善患者结局,并建立一个可适应FECD管理未来进展和不断演变技术的框架。
研究设计与样本
- 改良德尔菲全球共识,参与者为来自世界各地在FECD管理与机制方面具有丰富专业知识的37名眼科医生。
- 通过三轮结构化问题和陈述形成系列共识声明:前两轮为异步电子问卷,第三轮为线上实时会议。
- 专家匿名回答评估共识的陈述及邀请多元意见的开放式问题,共识定义为专家间70%同意。
主要发现
- 三轮后91条陈述中有90条达成共识。
- 专家一致认为FECD定义为存在中央或旁中央散在或融合的滴状疣,伴或不伴水肿。
- 强烈共识认为慢性亚临床水肿状态先于临床可检测水肿的出现,后者可伴或不伴症状。
- 以近乎一致共识,疾病评估建议包括评估提示角膜为视力下降来源的表现,以将其与共病影响区分,因为这些表现可提示角膜干预是否合适。
- 这些表现包括视力日间波动、临床或亚临床(断层成像)水肿,以及中央角膜厚度的变化或差异。
关键数值与推荐
- 共识定义为专家间70%同意。
- 三轮后91条陈述中有90条达成共识。
- 专家一致认为FECD定义为存在中央或旁中央散在或融合的滴状疣,伴或不伴水肿。
- 强烈共识认为慢性亚临床水肿状态先于临床可检测水肿的出现,后者可伴或不伴症状。
- 基于当前证据,专家一致认为FECD无有效药物治疗,有指征时Descemet膜内皮角膜移植术是首选手术治疗。
临床怎么用
- 专家一致认为FECD无有效药物治疗,有指征时Descemet膜内皮角膜移植术是首选手术治疗。
- 疾病评估建议包括评估提示角膜为视力下降来源的表现,以将其与共病影响区分,因为这些表现可提示角膜干预是否合适。
- 这些评估表现包括视力日间波动、临床或亚临床(断层成像)水肿,以及中央角膜厚度的变化或差异。
- 该指南对通常首次诊断和评估FECD的普通眼科医生以及角膜专科医生具有重要性和相关性,使其能对照专家建议衡量自身实践模式。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify areas of consensus among global experts for the management of Fuchs endothelial corneal dystrophy (FECD) in clinical practice, including its diagnosis, evaluation, decision-making principles with respect to intervention, and recommendations for performing cataract surgery in patients with FECD, including when to combine with keratoplasty. DESIGN: Modified Delphi-based global consensus. PARTICIPANTS: Thirty-seven ophthalmologists from around the world with significant expertise in the management and mechanisms of FECD. METHODS: A series of consensus statements about FECD were developed from three iterative rounds of structured questions and statements posed to the panel of experts. Two rounds were asynchronous electronic questionnaires, and the third round was a live virtual meeting. Experts responded anonymously to statements assessing consensus and to open-ended questions that invited diverse input. MAIN OUTCOME MEASURES: Consensus was defined as 70% agreement among experts. RESULTS: Consensus was reached for 90 of 91 statements after three rounds. Experts agreed that FECD is defined by the presence of central or paracentral scattered or confluent guttae with or without edema. There was strong consensus that a chronic state of subclinical edema precedes the onset of clinically detectable edema that may or may not cause symptoms. With near-unanimous consensus, disease evaluation recommendations included assessing for findings that implicate the cornea as a source of decreased vision to separate it from the effect of comorbid conditions, as this would inform whether corneal intervention is appropriate. These findings include diurnal variation in vision, clinical or subclinical (tomographic) edema, and changes or differences in central corneal thickness. Based on current evidence, experts agreed that there are no effective medical therapies for FECD, and that Descemet membrane endothelial keratoplasty is the surgical treatment of choice when indicated. CONCLUSIONS: The consensus statements provide current globally endorsed recommendations for the diagnosis and management of FECD. The guidelines are important and relevant for general ophthalmologists, who typically first diagnose and evaluate FECD, and for cornea specialists, by allowing them to benchmark their current practice patterns against expert recommendations. This could help improve patient outcomes and establish a framework adaptable to future advances and evolving technologies in the management of FECD.
引用
- Patel SV, Gupta N, Bhogal M, et al. Delphi-Based Global Consensus on Fuchs Endothelial Corneal Dystrophy. An Endothelial Keratoplasty Learners Group Initiative. Am J Ophthalmol. 2025. PMID: 40789362. doi:10.1016/j.ajo.2025.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。